A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 49,503 shares of ARVN stock, worth $1.3 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
49,503
Previous 49,503 -0.0%
Holding current value
$1.3 Million
Previous $1.32 Billion 7.48%
% of portfolio
0.2%
Previous 0.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$19.64 - $28.21 $972,238 - $1.4 Million
49,503 New
49,503 $972 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.4B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Yelin Lapidot Holdings Management Ltd. Portfolio

Follow Yelin Lapidot Holdings Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yelin Lapidot Holdings Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Yelin Lapidot Holdings Management Ltd. with notifications on news.